Antares Pharma Inc. (ATRS)

3.20
NASDAQ : Health Technology
Prev Close 3.11
Day Low/High 3.13 / 3.23
52 Wk Low/High 2.53 / 3.96
Avg Volume 1.06M
Exchange NASDAQ
Shares Outstanding 163.06M
Market Cap 512.01M
P/E Ratio N/A
Div & Yield N.A. (N.A)
Antares Pharma Announces Closing Of Public Offering Of Common Stock

Antares Pharma Announces Closing Of Public Offering Of Common Stock

Antares Pharma, Inc. (NASDAQ: ATRS) today announced the closing of its previously announced firm commitment underwritten public offering of 12,500,000 shares of the Company’s common stock at a purchase price of ...

Antares Pharma Announces Pricing Of Public Offering Of Common Stock

Antares Pharma Announces Pricing Of Public Offering Of Common Stock

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that it has priced a firm commitment underwritten public offering of 12,500,000 shares of the Company’s common stock at a purchase price to the public of $4.

Antares Pharma Announces Proposed Public Offering Of Common Stock

Antares Pharma Announces Proposed Public Offering Of Common Stock

Antares Pharma, Inc. (NASDAQ: ATRS) today announced a public offering of shares of its common stock.

Antares Pharma Receives Development Milestone Payment

Antares Pharma Receives Development Milestone Payment

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that its partner Pfizer Inc.

Antares Pharma Announces Successful Results From VIBEX MTX Actual Human Use Study

Antares Pharma Announces Successful Results From VIBEX MTX Actual Human Use Study

Antares Pharma, Inc. (NASDAQ: ATRS) today announced positive results from an Actual Human Use (AHU) study for VIBEX Methotrexate (MTX).

5 Stocks Under $5 Moving Higher

5 Stocks Under $5 Moving Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Antares Pharma To Present At The Stifel Nicolaus 2012 Healthcare Conference

Antares Pharma To Present At The Stifel Nicolaus 2012 Healthcare Conference

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K.

Antares Pharma Inc. Stock Downgraded (ATRS)

Antares Pharma Inc. Stock Downgraded (ATRS)

Antares Pharma (Nasdaq:ATRS) has been downgraded by TheStreet Ratings from from a hold to sell.

Antares Pharma Reports Second Quarter 2012 Financial And Operating Results

Antares Pharma Reports Second Quarter 2012 Financial And Operating Results

Antares Pharma, Inc. (NASDAQ: ATRS) today reported financial and operating results for the second quarter ended June 30, 2012.

Antares Pharma To Host Second Quarter 2012 Earnings Call

Antares Pharma To Host Second Quarter 2012 Earnings Call

Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its second quarter 2012 financial results before the market opens on Wednesday, August 8, 2012, and host a conference call shortly thereafter at 8:30...

7 Stocks Under $10 With Relative Strength

7 Stocks Under $10 With Relative Strength

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Antares Pharma Appoints Jonathan S. Jaffe MD Vice President Of Clinical Development

Antares Pharma Appoints Jonathan S. Jaffe MD Vice President Of Clinical Development

Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Jonathan S.

Antares Stock Hits New 52-Week High (ATRS)

Antares Stock Hits New 52-Week High (ATRS)

Antares Pharma (Nasdaq:ATRS) hit a new 52-week high Tuesday as it is currently trading at $3.84, above its previous 52-week high of $3.75 with 325,626 shares traded as of 9:40 a.m. ET. Average volume has been one million shares over the past 30 days.

Antares Pharma Announces Positive Results From VIBEX MTX Usability Study

Antares Pharma Announces Positive Results From VIBEX MTX Usability Study

Antares Pharma, Inc. (NASDAQ: ATRS) today announced positive results from a human factors usability study for VIBEX Methotrexate (MTX), a proprietary auto injector product designed to self-administer a rapid ...

Should I Do It? Symantec Bar Set Low

Should I Do It? Symantec Bar Set Low

The market is pricing in a weak 2007, but near-term downside is limited and shares should lift.

Stocks Close Little Changed

Stocks Close Little Changed

The major averages end below their session highs.

Symantec Can't Break Spending Habit

Symantec Can't Break Spending Habit

Investors question whether it's time for another large buy.

Monday's Tech Winners & Losers

Altiris takes off, while Radware slumps.

Symantec Buying Altiris

The deal offers a 22% premium.

Tuesday's Tech Winners & Losers

Tuesday's Tech Winners & Losers

iRobot catches a bid after narrowing its loss.

Tuesday's Early Winners & Losers

Tuesday's Early Winners & Losers

PeopleSupport and Altiris post stronger-than-expected second-quarter results.

Tuesday's Small-Cap Winners & Losers

Tuesday's Small-Cap Winners & Losers

Altiris shares sink on an analyst downgrade.

StreetNotes: A Daily Roundup of Street Research

Who made what calls.

Early Stocks in Motion

Early Stocks in Motion

JDA Software and PortalPlayer post better-than-expected earnings.

Macrovision Protects the Big Picture

The content security company is in the midst of a turnaround that could be helped by the advent of the video iPod.

Tech Stocks in Motion

Tech Stocks in Motion

Secure Computing rises 16% on raised first-quarter guidance.

Tech Stocks in Motion

Tech Stocks in Motion

Silicon Labs is hammered on anemic revenue guidance.

When Charts Alone Aren't Enough

Traders often need to look past the price action. Also, keep an eye on Altiris.

A Few Software Names Seen Heating Up

A Few Software Names Seen Heating Up

Deutsche Bank sees a cyclical recovery, although some shares are already priced for it.

Watch for Shifts in Supply and Demand

Any chart pattern can be explained in those terms. Plus, charts of Rowan, Blockbuster and more.

TheStreet Quant Rating: C (Hold)